Top Markets
#1 Useless Coin Useless Coin +39.03%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.96%
#3 0G 0G +36.39%
#4 StonkBroker StonkBroker +35.78%
#5 SAFEcoin SAFEcoin +29.23%
#6 Arbitrum Arbitrum +22.61%
#7 Zora Zora +20.61%
#8 Full Moon Full Moon +18.06%
#9 Notcoin Notcoin +18.04%
#10 Dogs Dogs +17.45%
Coin of the day
Useless Coin Useless Coin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Pozycja w akcjach #13828
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Cena akcji
$4.36
Kapitalizacja rynkowa
$457.32M
Zmiana (1 dzień)
0.69%
Zmiana (1 rok)
289.29%
Kraj
US
Handel Relmada Therapeutics, Inc. (RLMD)

Kategoria

Healthcare
Historia ceny akcji dla Relmada Therapeutics, Inc. (RLMD)
Najwyższa cena zamknięcia: $4.68 dnia 2026-08-01

Najniższa cena zamknięcia: $11.43 dnia 2014-06-01
Historia cen akcji firmy Relmada Therapeutics, Inc. od 2014 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 10.22%
2025 860.47%
2024 -36.35%
2023 -17.50%
2022 -78.37%
2021 -41.31%
2020 -14.84%
2019 756.21%
2018 52.34%
2017 -6.63%
2016 -71.17%
2015 -80.90%
2014 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.87%
CH